NCT00060866View on ClinicalTrials.gov

Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

March 31, 2005

Conditions
Neurocardiogenic Syncope
Interventions
DRUG

Propranolol

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00060866 - Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance | Biotech Hunter | Biotech Hunter